RFK Jr meets senators on questions of Trump's pick to lead health agency

The man known simply as RFK, Jr., is the latest in the Trump rival-turned-partner orbit, a former Democratic presidential hopeful now in line to run the world's largest public health agency

Robert F Kennedy Jr
Kennedy's first stop Monday was on potentially friendly terrain, to the offices of GOP senators allied with Trump, the start of a weeks-long process | (Photo: Wikipedia)
AP
3 min read Last Updated : Dec 17 2024 | 7:48 AM IST

Robert F. Kennedy Jr. swept onto Capitol Hill late Monday, as the anti-vaccine health guru from the famous political family reintroduced himself to senators, this time as President-elect Donald Trump's pick to lead the nation's Health and Human Services Department.

It was a soft-opening debut for Kennedy, whose wide-ranging views yes to raw milk, no to fluoride, Ozempic and America's favourite processed foods are raising alarms in the scientific community and beyond. In the Senate he's facing a mix of support, curiosity, skepticism and downright rejection among the senators who will be asked to confirm him to Trump's Cabinet.

Kennedy's first stop Monday was on potentially friendly terrain, to the offices of GOP senators allied with Trump, the start of a weeks-long process.

Ahead of the nominee's visits, Trump said he's a big believer in polio vaccines and sought to tamp down fears about Kennedy, saying he will be much less radical than people think.

The man known simply as RFK, Jr., is the latest in the Trump rival-turned-partner orbit, a former Democratic presidential hopeful now in line to run the world's largest public health agency, with its whopping $ 1.7 trillion budget, and some of the US most important public services.

HHS has a broad reach across the lives of Americans inspecting the nation's food, regulating medicines and overseeing research of diseases and cures. It provides health insurance for nearly half of the country poor, disabled and older Americans, including via Medicare.

Richard Besser, CEO of the Robert Wood Johnson Foundation and former acting director of the Centers for Disease Control and Prevention, called Kennedy a truly dangerous choice.

Besser, in an op-ed in US News and World Report, said Kennedy, 70, stands out as a single potential Cabinet member who could do the most damage to the American people's lives.

Ahead of Kennedy's arrival he was given a word of advice from one important voice: outgoing Senate GOP Leader Mitch McConnell, a childhood polio survivor, who cautioned the nominee against views opposing the vaccine.

Anyone seeking the Senate's consent to serve in the incoming Administration would do well to steer clear of even the appearance of association with such efforts, McConnell said recently.

The incoming GOP leader, Sen. John Thune of South Dakota, said Kennedy will have to address questions about his views on the polio vaccine and other issues.

Well I think he'll have to address that, Thune said. We'll find out.

But hardline Rep. Marjorie Taylor Greene of Georgia, a House member who has no vote in the confirmation process, has been influential in supporting and amplifying Kennedy's views on vaccines.

And GOP Sen. Thom Tillis of North Carolina said his mind is not made up. I'm open. I'm not predisposed one way or the other, Tillis said Monday evening.

Kennedy's nomination will test the nation's emerging political realignment, as Trump expands his base of supporters to include former Democratic voters shifting elsewhere. Kennedy's views find favour but also also opposition from both sides of the political aisle.

Other Trump nominees are also expected back on Capitol Hill this week. The president-elect's choice of Pete Hegseth for Defense Secretary, Tulsi Gabbard for Office of the Director of National Intelligence, Kash Patel for FBI director and others are all running into turbulence from wary senators.

With Republicans taking control of the Senate in the new year, Trump's nominees have a pathway to confirmation. But with just a 53-47 majority, any nominee can only lose a handful of GOP supporters, in the face of Democratic opposition.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Trump Inauguration 2025Donald TrumpUS healthcareDonald Trump administrationUS government

First Published: Dec 17 2024 | 7:48 AM IST

Next Story